|
OMIM |
Link |
Information gain |
01 |
|
PTH
|
[NCBI]
|
0.00252486
|
|
|
HBD
|
[NCBI]
|
0.0024927
|
|
|
IS1
|
[NCBI]
|
0.00183074
|
|
|
natural killer cell deficiency, familial isolated
|
[NCBI]
|
0.000847142
|
|
|
megalocornea-mental retardation syndrome
|
[NCBI]
|
0.000539786
|
|
|
DBQD
|
[NCBI]
|
0.000525644
|
|
|
TNFRSF11B
|
[NCBI]
|
0.000522139
|
|
|
BGLAP
|
[NCBI]
|
0.000493346
|
|
|
HEPOD
|
[NCBI]
|
0.000200868
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
0.000142199
|
|
|
ACP5
|
[NCBI]
|
0.000118126
|
|
|
xanthinuria, type ii
|
[NCBI]
|
0.000113208
|
|
|
osteopenia and sparse hair
|
[NCBI]
|
0.000113208
|
|
|
RA
|
[NCBI]
|
0.000100954
|
|
|
LEPRE1
|
[NCBI]
|
9.81544e-05
|
|
|
VDR
|
[NCBI]
|
9.34716e-05
|
|
|
osteogenesis imperfecta, type iib
|
[NCBI]
|
8.22828e-05
|
|
|
bone fragility with craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features
|
[NCBI]
|
8.22828e-05
|
|
|
osteogenesis imperfecta, type vii
|
[NCBI]
|
7.67894e-05
|
|
|
satoyoshi syndrome
|
[NCBI]
|
7.67894e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
7.27084e-05
|
|
|
CD
|
[NCBI]
|
6.67799e-05
|
|
|
GDD
|
[NCBI]
|
6.4451e-05
|
|
|
RUNX2
|
[NCBI]
|
6.25909e-05
|
|
|
weill-marchesani syndrome, autosomal recessive
|
[NCBI]
|
6.06443e-05
|
|
|
NSHPT
|
[NCBI]
|
5.62372e-05
|
|
|
xanthinuria, type i
|
[NCBI]
|
5.27934e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
5.27934e-05
|
|
|
SLC30A5
|
[NCBI]
|
5.19898e-05
|
|
|
SP7
|
[NCBI]
|
5.19898e-05
|
|
|
osteoporosis, juvenile
|
[NCBI]
|
5.17945e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
4.99693e-05
|
|
|
SCN1
|
[NCBI]
|
4.91306e-05
|
|
|
FGF23
|
[NCBI]
|
4.87267e-05
|
|
|
CRTAP
|
[NCBI]
|
4.68017e-05
|
|
|
SIAH1
|
[NCBI]
|
4.34371e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
3.92211e-05
|
|
|
PPIB
|
[NCBI]
|
3.89504e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
3.87979e-05
|
|
|
IL6ST
|
[NCBI]
|
3.72992e-05
|
|
|
CALCR
|
[NCBI]
|
3.46549e-05
|
|
|
IFNB1
|
[NCBI]
|
3.46549e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
3.41672e-05
|
|
|
MMP14
|
[NCBI]
|
3.35614e-05
|
|
|
SOST
|
[NCBI]
|
3.35614e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
3.27115e-05
|
|
|
PAX5
|
[NCBI]
|
3.16873e-05
|
|
|
CD44
|
[NCBI]
|
3.08713e-05
|
|
|
CF
|
[NCBI]
|
3.07674e-05
|
|
|
EGF
|
[NCBI]
|
3.03598e-05
|
|
|
KLK3
|
[NCBI]
|
2.83457e-05
|
|
|
SLC12A3
|
[NCBI]
|
2.81635e-05
|
|
|
FOS
|
[NCBI]
|
2.75917e-05
|
|
|
GAD2
|
[NCBI]
|
2.75917e-05
|
|
|
CCD
|
[NCBI]
|
2.63306e-05
|
|
|
LRP5
|
[NCBI]
|
2.60584e-05
|
|
|
RPS6KA3
|
[NCBI]
|
2.47404e-05
|
|
|
AHO
|
[NCBI]
|
2.39061e-05
|
|
|
APS1
|
[NCBI]
|
2.3327e-05
|
|
|
GLB1
|
[NCBI]
|
2.13486e-05
|
|
|
MAS
|
[NCBI]
|
2.1116e-05
|
|
|
IRS1
|
[NCBI]
|
2.10694e-05
|
|
|
DBA
|
[NCBI]
|
2.0997e-05
|
|
|
CYP19A1
|
[NCBI]
|
2.02804e-05
|
|
|
MDD
|
[NCBI]
|
2.00427e-05
|
|
|
coproporphyria
|
[NCBI]
|
2.00321e-05
|
|
|
PMD
|
[NCBI]
|
1.97567e-05
|
|
|
TNF
|
[NCBI]
|
1.92376e-05
|
|
|
SMAX1
|
[NCBI]
|
1.8434e-05
|
|
|
TNFSF11
|
[NCBI]
|
1.58315e-05
|
|
|
ESR1
|
[NCBI]
|
1.45726e-05
|
|
|
IHH
|
[NCBI]
|
1.44439e-05
|
|
|
AR
|
[NCBI]
|
1.0701e-05
|
|
|
LRP1
|
[NCBI]
|
9.71168e-06
|
|
|
IL6
|
[NCBI]
|
9.50914e-06
|
|
|
WAS
|
[NCBI]
|
8.80637e-06
|
|
|
AKR1B1
|
[NCBI]
|
7.56149e-06
|
|
|
INS
|
[NCBI]
|
5.53607e-06
|
|
|
TNFSF10
|
[NCBI]
|
5.042e-06
|
|
|
phenylketonuria
|
[NCBI]
|
4.97968e-06
|
|
|
FGFR3
|
[NCBI]
|
4.85739e-06
|
|
|
PRL
|
[NCBI]
|
4.46503e-06
|
|
|
temporal arteritis
|
[NCBI]
|
4.40021e-06
|
|
|
HGF
|
[NCBI]
|
3.34271e-06
|
|
|
PWS
|
[NCBI]
|
1.44979e-06
|
|
|
PTK2
|
[NCBI]
|
9.50803e-07
|
|
|
CFTR
|
[NCBI]
|
8.96673e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
6.92463e-07
|
|
|
PTHLH
|
[NCBI]
|
6.633e-07
|
|
|
PPARA
|
[NCBI]
|
3.73141e-07
|
|
|
VIP
|
[NCBI]
|
3.24098e-07
|
|
|
TNFSF6
|
[NCBI]
|
2.16641e-07
|
|
|
SLE
|
[NCBI]
|
3.3853e-10
|
|